MOTP Clinical Trials

Potential study candidates

Potential study candidates are identified through the multidisciplinary transplant team, and approached by a research coordinator if they meet study criteria. Often patients are not seen until they are admitted for their organ transplant. Participation in any of our studies is completely voluntary, and every attempt is made to be able to offer these opportunities to all of our Atlantic Canada residents. Many patients feel they received additional, valuable care while in the study which is beneficial to their total well-being.

Current Studies

Some current studies include:
  • Frailty and the Transplant Waitlist

  • A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant

  • A randomized, parallel-group, double-blind, placebo-controlled, multi-center study of Eculizumab for the prevention of delayed graft function after kidney transplantation in adult subjects at increased risk of delayed graft function

  • A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-seronegative Kidney Transplant Recipients Receiving an Organ from a CMV-seropositive Donor

  • A Comparison of Effects of Standard Dose Versus Low Dose Advagraf With IL-2 Receptor Antibody Induction, MMF and Steroids, With or Without ACEi/ARB – Based Antihypertensive Therapy on Renal Allograft Histology, Function and Immune Response

  • A Long-Term Follow-up of Adult Kidney and Liver Allograft Recipients Previously Enrolled Into a Tacrolimus (Advagraf) Trial. A Multicentre Non-Interventional Post Authorization Study

  • Long-term Effects of Becoming a Living Kidney Donor Study

Hotel Room